Abstract
OBJECTIVE: We undertook this investigation to characterize conflict of interest (COI) policies of biomedical journals with respect to authors, peer-reviewers, and editors, and to ascertain what information about COI disclosures is publicly available.
METHODS: We performed a cross-sectional survey of a convenience sample of 135 editors of peer-reviewed biomedical journals that publish original research. We chose an international selection of general and specialty medical journals that publish in English. Selection was based on journal impact factor, and the recommendations of experts in the field. We developed and pilot tested a 3-part web-based survey. The survey included questions about the presence of specific policies for authors, peer-reviewers, and editors, specific restrictions on authors, peer-reviewers, and editors based on COI, and the public availability of these disclosures. Editors were contacted a minimum of 3 times.
RESULTS: The response rate for the survey was 91 (67%) of 135, and 85 (93%) of 91 journals reported having an author COI policy. Ten (11%) journals reported that they restrict author submissions based on COI (e.g., drug company authors’ papers on their products are not accepted). While 77% report collecting COI information on all author submissions, only 57% publish all author disclosures. A minority of journals report having a specific policy on peer-reviewer 46% (42/91) or editor COI 40% (36/91); among these, 25% and 31% of journals state that they require recusal of peer-reviewers and editors if they report a COI. Only 3% of respondents publish COI disclosures of peer-reviewers, and 12% publish editor COI disclosures, while 11% and 24%, respectively, reported that this information is available upon request.
CONCLUSION: Many more journals have a policy regarding COI for authors than they do for peer-reviewers or editors. Even author COI policies are variable, depending on the type of manuscript submitted. The COI information that is collected by journals is often not published; the extent to which such “secret disclosure” may impact the integrity of the journal or the published work is not known.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294:110–1.
Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and accountability. N Engl J Med. 2001;345:825–6; discussion 826–7.
Stelfox HT, Chua G, O’Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338:101–6.
Krimsky S, Rothenberg LS, Stott P, Kyle G. Financial interests of authors in scientific journals: a pilot study of 14 publications. Sci Eng Ethics. 1996;2:395–410.
Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004;19:51–6.
Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J. 2004;170:477–80.
Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167–70.
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials. A reflection of treatment effect or adverse events? JAMA. 2003;290:921–8.
Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287:612–7.
Kjaergard LL, Als-Nielsen B. Association between competing interests and author’s conclusions: epidemiological study of randomized clinical trials published in the BMJ. BMJ. 2002;325:249–52.
Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract. 2001;18:565–8.
World Association of Medical Editors (WAME). WAME recommendations on publication ethics policles for medical journals. Available at http://wame.org/pubethicrecom.htm#conflicts. Accessed August 22, 2005.
International Council of Medical Journal Editors (ICMJE). Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Available at http://www.icmje.org/#conflicts. Accessed August 22, 2005.
Committee on Publication Ethics (COPE). A code of conduct for editors of biomedical journals. Available at http://www.bmjpg.com/cope/guidelines/. Accessed August 22, 2005.
Haivas I, Schroter S, Waechter F, Smith R. Editors declaration of their own conflicts of interest. Can Med Assoc J. 2004;171:475–6.
ISI Web of Knowledge Journal Database Version 2005. Available at http://www.thomsonisi.com/. Accessed January 27, 2005.
Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. [PLoS Med 2005 May 2:e138, DOI: 10.1371/journal.pmed.0020138].
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was previously reported at the Fifth International Congress on Peer Review and Biomedical Publication held September 16 to 18, 2005, in Chicago, IL.
Funding: There was no funding source for this study.
Declaration of potential COI: Richelle Cooper is on the Editorial Board of Annals of Emergency Medicine and receives a stipend for providing editorial services. All other authors report no COI to declare.
Rights and permissions
About this article
Cite this article
Cooper, R.J., Gupta, M., Wilkes, M.S. et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J GEN INTERN MED 21, 1248–1252 (2006). https://doi.org/10.1111/j.1525-1497.2006.00598.x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2006.00598.x